Yong Rae Hong

USPTO Granted Patents = 3 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 25(Granted Patents)

Company Filing History:

3 out of 10

Crystalgenomics, Inc.

patents

Years Active: 2017-2022

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11230539 - 2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same (2022-01-25),

2. 10604508 - 2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same (2020-03-31),

3. 9758508 - 2,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same (2017-09-12),

Title: Yong Rae Hong - Innovative Inventor from Gyeonggi-do, South Korea

Introduction: Yong Rae Hong is a distinguished inventor hailing from Gyeonggi-do, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yong Rae Hong holds several patents in the areas of electronics, telecommunications, and renewable energy, showcasing his versatility and expertise in various domains.

Career Highlights: Throughout his illustrious career, Yong Rae Hong has worked with leading tech companies, research institutions, and universities, playing a pivotal role in developing cutting-edge technologies that have revolutionized the industry.

Collaborations: Yong Rae Hong has collaborated with top inventors, patent attorneys, and companies worldwide, fostering a culture of innovation and knowledge sharing that has led to the creation of impactful inventions.

Conclusion: Yong Rae Hong's passion for innovation, coupled with his relentless pursuit of excellence, has solidified his reputation as a visionary inventor shaping the future of technology in South Korea and beyond.

This text is generated by artificial intelligence and may not be accurate.